Browse
Search
Agenda - 06-01-2021; 6-a - Opioid Litigation Memorandum of Agreement
OrangeCountyNC
>
Board of County Commissioners
>
BOCC Agendas
>
2020's
>
2021
>
Agenda - 06-01-2021 Virtual Business Meeting
>
Agenda - 06-01-2021; 6-a - Opioid Litigation Memorandum of Agreement
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
5/27/2021 11:50:05 AM
Creation date
5/27/2021 12:00:19 PM
Metadata
Fields
Template:
BOCC
Date
6/1/2021
Meeting Type
Business
Document Type
Agenda
Agenda Item
6-a
Document Relationships
RES-2021-036-RESOLUTION Opioid Litigation Memorandum of agreement
(Message)
Path:
\Board of County Commissioners\Resolutions\2020-2029\2021
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
44
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
27 <br /> PART TWO: PREVENTION <br /> F. PREVENT OVER-PRESCRIBING AND ENSURE APPROPRIATE PRESCRIBING <br /> AND DISPENSING OF OPIOIDS <br /> Support efforts to prevent over-prescribing and ensure appropriate prescribing and dispensing of <br /> opioids through evidence-based or evidence-informed programs or strategies that may include,but <br /> are not limited to, the following: <br /> 1. Fund medical provider education and outreach regarding best prescribing practices for opioids <br /> consistent with Guidelines for Prescribing Opioids for Chronic Pain from the U.S. Centers for <br /> Disease Control and Prevention, including providers at hospitals (academic detailing). <br /> 2. Training for health care providers regarding safe and responsible opioid prescribing, dosing, <br /> and tapering patients off opioids. <br /> 3. Continuing Medical Education(CME) on appropriate prescribing of opioids. <br /> 4. Support for non-opioid pain treatment alternatives, including training providers to offer or refer <br /> to multi-modal, evidence-informed treatment of pain. <br /> 5. Support enhancements or improvements to Prescription Drug Monitoring Programs (PDMPs), <br /> including but not limited to improvements that: <br /> a. Increase the number of prescribers using PDMPs; <br /> b. Improve point-of-care decision-making by increasing the quantity, quality, or format of <br /> data available to prescribers using PDMPs, by improving the interface that prescribers use <br /> to access PDMP data, or both; or <br /> c. Enable states to use PDMP data in support of surveillance or intervention strategies, <br /> including MAT referrals and follow-up for individuals identified within PDMP data as <br /> likely to experience OUD in a manner that complies with all relevant privacy and security <br /> laws and rules. <br /> 6. Ensuring PDMPs incorporate available overdose/naloxone deployment data, including the <br /> United States Department of Transportation's Emergency Medical Technician overdose database <br /> in a manner that complies with all relevant privacy and security laws and rules. <br /> 7. Increase electronic prescribing to prevent diversion or forgery. <br /> 8. Educate Dispensers on appropriate opioid dispensing. <br /> G. PREVENT MISUSE OF OPIOIDS <br /> Support efforts to discourage or prevent misuse of opioids through evidence-based or evidence- <br /> informed programs or strategies that may include, but are not limited to, the following: <br /> Exhibits,page 9 <br />
The URL can be used to link to this page
Your browser does not support the video tag.